The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Stocks•26 April 2026•

1 min read

M&T Bank Corp Executes Major Portfolio Rebalancing Affecting IBM and CRL

Key Facts

1M&T Bank Corp reduced its stake in IBM by 94.5%, selling 378,671 shares during the fourth quarter.

2The bank increased its holdings in Charles River Laboratories by 1,424.9% to 27,997 shares.

3The bank sold 175,456 shares of American Tower Corporation, reducing its position by 84.4%.

M&T Bank Corp executed significant portfolio adjustments during the fourth quarter, marked by a massive 94.5% reduction in its IBM stake through the sale of 378,671 shares. Conversely, the bank showed a strong bullish conviction in Charles River Laboratories (CRL), increasing its holdings by 1,424.9% to reach 27,997 shares. The rebalancing also impacted American Tower Corporation (AMT), where the bank liquidated 175,456 shares, slashing its position by 84.4%. These strategic moves reflect institutional rebalancing, with CRL seeing accumulation following an earnings beat and positive long-term guidance for 2026. Despite IBM's stable earnings and dividend hikes, the aggressive selling by M&T Bank highlights a shift in institutional sentiment. These adjustments underscore a tactical rotation within the bank's equity portfolio across the technology and healthcare sectors.

Version History

3 additional sources confirmed this story